Filing Flows › Stoke Therapeutics (STOK) › How it makes money
How Stoke Therapeutics (STOK) makes money
Stoke Therapeutics (STOK) made $11.3M of revenue in the third quarter 2026 (Q3 2026), +6% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $11.3M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $11.3M | +6% |
| Q2 2026 | $9.3M | -32% |
| Q1 2026 | $6.2M | -96% |
| Q4 2025 | $1.4M | -94% |
| Q3 2025 | $10.6M | +117% |
| Q2 2025 | $13.8M | +186% |
| Q1 2025 | $159M | 38× |
From Stoke Therapeutics' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Stoke Therapeutics make money?
Stoke Therapeutics (STOK) made $11.3M of revenue in the third quarter 2026 (Q3 2026), +6% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.